Results 11 to 20 of about 135,991 (315)

Knowledge, perceptions and attitude of Egyptian physicians towards biobanking issues.

open access: yesPLoS ONE, 2021
ObjectivesCollection and storage of biospecimens and data for biobanking raise many ethical concerns. Stakeholders' opinions about these ethical issues are important since they can help in the development of ethical guidelines to govern biobanking ...
Ahmed Samir Abdelhafiz   +4 more
doaj   +1 more source

The introduction of sickness insurance in Spain in the first decades of the Franco dictatorship (1939-1962) [PDF]

open access: yes, 2013
[Abstract:]Using new statistical data on financing, coverage and economic and health care provisions, this article analyses how sickness insurance was introduced, managed and extended in Spain, under the Franco dictatorship, between 1939 and 1962. This
Pons Pons, Jerònia   +1 more
core   +1 more source

Industry payments to family medicine residents in Portugal: a descriptive analysis of the national transparency database

open access: yesBMJ Open, 2023
Objective To analyse payments made to family medicine residents by the pharmaceutical industry during their residency in Portugal, using mandatory disclosure data.Design and participants Cohort study of residents starting their family medicine training ...
Marta Ruivo   +2 more
doaj   +1 more source

The Distributed Partnering Model for Drug Discovery and Development [PDF]

open access: yes, 2010
Proposes a model for bringing new drugs to market efficiently by creating "product definition companies" that would acquire early-stage discoveries from research institutions and invest in defining product applications to sell to pharmaceutical ...
Duane Roth, Pedro Cuatrecasas
core   +1 more source

National medicines regulatory authorities financial sustainability in the East African Community.

open access: yesPLoS ONE, 2020
IntroductionAdequate and sustainable funding of national medicine regulatory agencies (NMRAs) is key for assurance of quality, safety and efficacy of medical products circulating in a market.
Margareth Ndomondo-Sigonda   +6 more
doaj   +1 more source

EFFICACY OF AUDIT FEE ON AUDIT QAULITY OF SELECTED PHARMACEUTICAL FIRMS IN NIGERIA

open access: yesCopernican Journal of Finance & Accounting, 2021
The problem of poor accuracy and credibility in some audited financial statement has being a major form of information asymmetry which had led some shareholders and prospective investors to make wrong Judgment about the financial position of some organization due to poor audit quality.
Daud Omotosho Saheed   +2 more
openaire   +3 more sources

The Function of Large Vessels in Normal-Weight and Overweight Children With Psoriasis During Methotrexate Therapy

open access: yesПедиатрическая фармакология, 2019
Background. In recent years, the opinion has been established that skin manifestations of psoriasis are associated with the damage of other organs and systems, and that psoriatic lesions have a systemic nature, and therefore the term ‘psoriatic disease ...
Nikolay N. Murashkin   +2 more
doaj   +1 more source

Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database.

open access: yesPLoS ONE, 2023
IntroductionAlthough hospitals are key health service providers, their financial ties to drug companies are little understood. We examine non-research pharmaceutical industry payments to English National Health Service (NHS) trusts-hospital groupings ...
Piotr Ozieranski   +2 more
doaj   +1 more source

Annual Accounting Reports - Information Source on the Assessment of the Financial Performance of the Economic Entity. Case Study: The Pharmaceutical Industry [PDF]

open access: yesAnnals of Dunarea de Jos University. Fascicle I : Economics and Applied Informatics, 2020
In order to determine the impact taxation has on the financial-economic performances, we must strongly consider the determination relations of the financial performance indexes based on the profit and loss account.
Mihaela Cristina Onica
doaj  

Expanding Medical Surge Capacity to Counteract COVID-19: South Korea’s Medical Fee Adjustment Through the National Health Insurance System

open access: yesRisk Management and Healthcare Policy, 2022
Eunji Yun,1 Hey Jin Ko,2 Boryung Ahn,3 Hyejin Lee,4,5 Won Mo Jang,6,7,* Jin Yong Lee7,8,* 1Division of Pharmaceutical Policy Research, HIRA Research Institute, Health Insurance Review & Assessment Service, Wonju-si, Gangwon-do, Republic of Korea;
Yun E   +5 more
doaj  

Home - About - Disclaimer - Privacy